Wendy Perrow is Director at BIOANALYTICAL SYSTEMS INC (BASI). They have made 1 open-market trade across 1 company since 2019, most recently 2019-09-10.
CIK 0001660814
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $36K since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BASI | 10,000 | $164K |
Shares reported on the most recent Form 4, priced at the 2019-09-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BASI | BUY | 2019-09-10 | 2019-09-11 | $3.62 | $36K | +15.7% | +1.4% | +23.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.